nivolumab,irinotecan,ipilimumab,regorafenib
bms,bayer
['irinotecan', 'rectal', ' 320mo', 'ipilimumab', 'regorafenib', 'nivo', 'crc,(-ccrcc),(-tbcrc049),(-mccrcc),(-mbcrc)', 'nivolumab', 'colorectal']
#esmo22 320mo a phase i clinical trial of regorafenib, ipilimumab, and nivolumab (rin) in chemotherapy resistant mss metastatic colorectal cancer (mcrc). mg fakih i/o in stage iv mss colorectal cancer patients rin - regorafenib
- irinotecan
- nivoluma a graphic to help. 
volunteer #CRCSM librarian
#BRAF & #NRAS FB grps
Stage 4 CRC Support & Colon Cancer Stars
trials Stage 2/3 pts
https://t.co/48vU5493pH